149 related articles for article (PubMed ID: 28841372)
21. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
[TBL] [Abstract][Full Text] [Related]
22. Nuclear magnetic resonance analysis of the acetylation pattern of the neuronal Tau protein.
Kamah A; Huvent I; Cantrelle FX; Qi H; Lippens G; Landrieu I; Smet-Nocca C
Biochemistry; 2014 May; 53(18):3020-32. PubMed ID: 24708343
[TBL] [Abstract][Full Text] [Related]
23. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors.
Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK
ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299
[TBL] [Abstract][Full Text] [Related]
24. C-H ... π interplay between Ile308 and Tyr310 residues in the third repeat of microtubule binding domain is indispensable for self-assembly of three- and four-repeat tau.
Sogawa K; Okuda R; In Y; Ishida T; Taniguchi T; Minoura K; Tomoo K
J Biochem; 2012 Sep; 152(3):221-9. PubMed ID: 22659094
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanism of tau aggregation induced by anionic and cationic dyes.
Lira-De León KI; García-Gutiérrez P; Serratos IN; Palomera-Cárdenas M; Figueroa-Corona Mdel P; Campos-Peña V; Meraz-Ríos MA
J Alzheimers Dis; 2013; 35(2):319-34. PubMed ID: 23435411
[TBL] [Abstract][Full Text] [Related]
26. Formaldehyde at low concentration induces protein tau into globular amyloid-like aggregates in vitro and in vivo.
Nie CL; Wei Y; Chen X; Liu YY; Dui W; Liu Y; Davies MC; Tendler SJ; He RG
PLoS One; 2007 Jul; 2(7):e629. PubMed ID: 17637844
[TBL] [Abstract][Full Text] [Related]
27. Multi-Vitamin B Supplementation Reverses Hypoxia-Induced Tau Hyperphosphorylation and Improves Memory Function in Adult Mice.
Yu L; Chen Y; Wang W; Xiao Z; Hong Y
J Alzheimers Dis; 2016 Aug; 54(1):297-306. PubMed ID: 27497480
[TBL] [Abstract][Full Text] [Related]
28. α-Linolenic acid inhibits Tau aggregation and modulates Tau conformation.
Desale SE; Dubey T; Chinnathambi S
Int J Biol Macromol; 2021 Jan; 166():687-693. PubMed ID: 33130263
[TBL] [Abstract][Full Text] [Related]
29. Interplay between I308 and Y310 residues in the third repeat of microtubule-binding domain is essential for tau filament formation.
Naruto K; Minoura K; Okuda R; Taniguchi T; In Y; Ishida T; Tomoo K
FEBS Lett; 2010 Oct; 584(19):4233-6. PubMed ID: 20837015
[TBL] [Abstract][Full Text] [Related]
30. Holo-BtuF stabilizes the open conformation of the vitamin B12 ABC transporter BtuCD.
Kandt C; Tieleman DP
Proteins; 2010 Feb; 78(3):738-53. PubMed ID: 19847921
[TBL] [Abstract][Full Text] [Related]
31. Impacts of Cd(II) on the conformation and self-aggregation of Alzheimer's tau fragment corresponding to the third repeat of microtubule-binding domain.
Jiang LF; Yao TM; Zhu ZL; Wang C; Ji LN
Biochim Biophys Acta; 2007 Nov; 1774(11):1414-21. PubMed ID: 17920001
[TBL] [Abstract][Full Text] [Related]
32. Remodeling of the conformational ensemble of the repeat domain of tau by an aggregation enhancer.
Akoury E; Mukrasch MD; Biernat J; Tepper K; Ozenne V; Mandelkow E; Blackledge M; Zweckstetter M
Protein Sci; 2016 May; 25(5):1010-20. PubMed ID: 26940799
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Tau amyloid fibril formation by folic acid: In-vitro and theoretical studies.
Ghasemzadeh S; Riazi GH
Int J Biol Macromol; 2020 Jul; 154():1505-1516. PubMed ID: 31751728
[TBL] [Abstract][Full Text] [Related]
34. Evidence for an intermediate in tau filament formation.
Chirita CN; Kuret J
Biochemistry; 2004 Feb; 43(6):1704-14. PubMed ID: 14769048
[TBL] [Abstract][Full Text] [Related]
35. Soluble oligomers from a non-disease related protein mimic Abeta-induced tau hyperphosphorylation and neurodegeneration.
Vieira MN; Forny-Germano L; Saraiva LM; Sebollela A; Martinez AM; Houzel JC; De Felice FG; Ferreira ST
J Neurochem; 2007 Oct; 103(2):736-48. PubMed ID: 17727639
[TBL] [Abstract][Full Text] [Related]
36. Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells.
Pickhardt M; Larbig G; Khlistunova I; Coksezen A; Meyer B; Mandelkow EM; Schmidt B; Mandelkow E
Biochemistry; 2007 Sep; 46(35):10016-23. PubMed ID: 17685560
[TBL] [Abstract][Full Text] [Related]
37. The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In Vitro.
Khosravi Z; Nasiri Khalili MA; Moradi S; Hassan Sajedi R; Zeinoddini M
Cell J; 2018 Jan; 19(4):569-577. PubMed ID: 29105391
[TBL] [Abstract][Full Text] [Related]
38. Prediction of nucleating sequences from amyloidogenic propensities of tau-related peptides.
Rojas Quijano FA; Morrow D; Wise BM; Brancia FL; Goux WJ
Biochemistry; 2006 Apr; 45(14):4638-52. PubMed ID: 16584199
[TBL] [Abstract][Full Text] [Related]
39. Evaluating triggers and enhancers of tau fibrillization.
Kuret J; Congdon EE; Li G; Yin H; Yu X; Zhong Q
Microsc Res Tech; 2005 Jul; 67(3-4):141-55. PubMed ID: 16103995
[TBL] [Abstract][Full Text] [Related]
40. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.
Jeganathan S; von Bergen M; Mandelkow EM; Mandelkow E
Biochemistry; 2008 Oct; 47(40):10526-39. PubMed ID: 18783251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
